We assessed our muscle biopsy samples by qRT-PCR and observed a significant, albeit a much smaller fold-increase (< 2-fold), in Smad2 mRNA in ALS versus disease controls (Fig 7A). The gene discussed is SMAD2; the disease is amyotrophic lateral sclerosis.